These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30359859)

  • 41. Computational methods in determination of pharmacophore models of 5-HT(1A), 5-HT(2A) and 5-HT(7) receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Jun; 13(7):933-51. PubMed ID: 23544602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3D-QSAR study indicates an enhancing effect of membrane ions on psychiatric drugs targeting serotonin receptor 5-HT1A.
    Avram S; Milac AL; Mihailescu D
    Mol Biosyst; 2012 Apr; 8(5):1418-25. PubMed ID: 22373544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method.
    Pourbasheer E; Shokouhi Tabar S; Masand VH; Aalizadeh R; Ganjali MR
    SAR QSAR Environ Res; 2015 Jun; 26(6):461-77. PubMed ID: 26055215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist.
    Picard M; Morisset S; Cloix JF; Bizot JC; Guerin M; Beneteau V; Guillaumet G; Hevor TK
    Neuroscience; 2010 Sep; 169(3):1337-46. PubMed ID: 20580787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.
    Asagarasu A; Matsui T; Hayashi H; Tamaoki S; Yamauchi Y; Minato K; Sato M
    J Med Chem; 2010 Nov; 53(21):7549-63. PubMed ID: 20931963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT
    Franchini S; Manasieva LI; Sorbi C; Battisti UM; Fossa P; Cichero E; Denora N; Iacobazzi RM; Cilia A; Pirona L; Ronsisvalle S; Aricò G; Brasili L
    Eur J Med Chem; 2017 Jan; 125():435-452. PubMed ID: 27689727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.
    Floresta G; Apirakkan O; Rescifina A; Abbate V
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo.
    Valhondo M; Marco I; Martín-Fontecha M; Vázquez-Villa H; Ramos JA; Berkels R; Lauterbach T; Benhamú B; López-Rodríguez ML
    J Med Chem; 2013 Oct; 56(20):7851-61. PubMed ID: 24050112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular design of 1,3,5,7-TetraCN derivatives with reduced bioconcentration using 3D-QSAR modeling, full factorial design, and molecular docking.
    Zhao Y; Gu W; Li Y
    J Mol Graph Model; 2018 Sep; 84():197-214. PubMed ID: 30029045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors.
    Heusler P; Bruins Slot L; Tourette A; Tardif S; Cussac D
    Eur J Pharmacol; 2011 Nov; 669(1-3):51-8. PubMed ID: 21835172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A
    Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atom-based and Pharmacophore-based 3D - QSAR Studies on Vitamin D Receptor (VDR).
    Nagamani S; Kesavan C; Muthusamy K
    Comb Chem High Throughput Screen; 2018; 21(5):329-343. PubMed ID: 29874993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
    Huang M; Horiguchi M; Felix AR; Meltzer HY
    Neuroreport; 2012 May; 23(7):436-40. PubMed ID: 22415605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemical manipulations on the 1,4-dioxane ring of 5-HT
    Del Bello F; Bonifazi A; Giorgioni G; Quaglia W; Amantini C; Morelli MB; Santoni G; Battiti FO; Vistoli G; Cilia A; Piergentili A
    Eur J Med Chem; 2019 Apr; 168():461-473. PubMed ID: 30844609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Dekeyne A; Rivet JM; Gobert A; Millan MJ
    Neuropharmacology; 2001 Jun; 40(7):899-910. PubMed ID: 11378160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
    Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
    Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT
    Guariento S; Franchini S; Tonelli M; Fossa P; Sorbi C; Cichero E; Brasili L
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):214-230. PubMed ID: 28114832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.
    Pettersson M; Campbell BM; Dounay AB; Gray DL; Xie L; O'Donnell CJ; Stratman NC; Zoski K; Drummond E; Bora G; Probert A; Whisman T
    Bioorg Med Chem Lett; 2011 Jan; 21(2):865-8. PubMed ID: 21185183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.
    Newman-Tancredi A; Rivet JM; Cussac D; Touzard M; Chaput C; Marini L; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):188-99. PubMed ID: 12923612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.